Back to Journals » OncoTargets and Therapy » Volume 15

Letter

A Response to Article Anlotinib Hydrochloride and PD-1 Blockade as a Salvage Second-Line Treatment in Patients with Progress of Local Advanced Non-Small Cell Lung Cancer in Half a Year after Standard Treatment [Letter]

       
Total article views   HTML views PDF downloads Totals
2,738 Dovepress* 2,686+ 60 2,746
PubMed Central* 52 33 85
Totals 2,738 93 2,831
*Since 22 November 2022

View citations on PubMed Central and Google Scholar